Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%)等
02/14 16:55 (美東)
Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%)等
02/14 16:03 (美東)
Bellerophon Therapeutics | SC 13G:超過5%持股股東披露文件-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%)等
01/26 10:49 (美東)
Bellerophon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等
2023/10/17 21:05 (美東)
Bellerophon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等
2023/10/16 20:56 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-股東 Puissance Capital Management LP
2023/10/16 20:51 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-董事 Amin Naseem
2023/06/09 16:12 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-高管 Fernandes Peter
2023/06/09 16:12 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-高管 Shah Parag Suresh
2023/06/09 16:11 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-高管 Dekker Martin
2023/06/09 16:11 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-董事 Bruder Scott P
2023/06/09 16:11 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-高管 Kim Bobae
2023/06/09 16:10 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-董事 Wang Theodore T
2023/06/09 16:10 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-董事 Cloyd Mary Ann
2023/06/09 16:10 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-董事 Teufel Crispin
2023/06/09 16:10 (美東)
Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)
2023/06/09 13:03 (美東)
Bellerophon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%)等
2023/06/07 21:44 (美東)
Bellerophon Therapeutics | 4:持股變動聲明-股東 Puissance Life Science Opportunities Fund VI
2023/06/07 21:21 (美東)
Bellerophon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(12.1%),Janus Henderson Biotech Innovation Master Fund Ltd(10.4%)
2023/05/26 16:41 (美東)
Bellerophon Therapeutics | SC 13G:超過5%持股股東披露文件-Janus Henderson Group plc(5.1%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
2023/05/25 11:17 (美東)
暫無數據
暫無數據